Spyre Therapeutics (SYRE) CFO exercises options and sells 7,500 shares under 10b5-1 plan – Stock Titan
News brief
Spyre Therapeutics (SYRE) CFO exercises options and sells 7,500 shares under 10b5-1 plan Stock Titan Select “More options” to see additional information, including details about managing your privacy settings. You can also visit g.co/privacytools at any time.
Why traders care
For traders, this matters because equity-specific headlines can influence sector leadership, index tone and short-term volatility around positioning.
What to watch next
- Watch whether the reaction stays isolated to one name or spills into the broader sector, index futures and correlated risk assets.
Spyre Therapeutics (SYRE) CFO exercises options and sells 7,500 shares under 10b5-1 plan Stock Titan Select “More options” to see additional information, including details about managing your privacy settings. You can also visit g.co/privacytools at any time. Select “More options” to see additional information, including details about managing your privacy settings. You can also visit g.co/privacytools at any time. For traders, this matters because equity-specific headlines can influence sector leadership, index tone and short-term volatility around positioning. Watch whether the reaction stays isolated to one name or spills into the broader sector, index futures and correlated risk assets.
